Investigation of the levels of circulating miR-29a, miR-122, sestrin 2 and inflammatory markers in obese children with/without type 2 diabetes: a case control study

BMC Endocr Disord. 2021 Aug 3;21(1):152. doi: 10.1186/s12902-021-00829-z.

Abstract

Aim: The present work investigated serum levels of miR-29a, miR-122 and sestrin2 in obese children with/without type-2-diabetes mellitus (T2DM), and their correlations with inflammatory, metabolic and anthropometric parameters.

Methods: The study included 298 children, divided into: G1 (control, n = 136), G2 (obese without diabetes, n = 90) and G3 (obese with T2DM, n = 72). Metabolic and anthropometric parameters, miR-29a, miR-122 relative expressions, and sestrin2, high sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) levels were measured by their specific methods. The data was processed and analyzed by SPSS V.26 using the corresponding tests. After testing the variables' normality, Kruskal-Wallis one-way-ANOVA, Spearman correlations coefficient were used.

Results: Significant higher serum miR-29a, miR-122, IL-6, hsCRP and TNF-α and lower sestrin2 levels were found in G2 and G3 than G1 and in G3 than G2 (p= > 0.001 for all). Especially in G3, miR-29a and miR-122 levels correlated positively while sestrin2 levels correlated negatively with waist circumference and BMI percentiles, serum levels of LDL-cholesterol, triacylglycerol, total cholesterol, HbA1c%, glucose, insulin, c-peptide, homeostatic model assessment-insulin resistance (HOMA-IR), IL-6, hsCRP and TNF-α.

Conclusion: The change in the serum miR-29a, miR-122 and sestrin2 levels in obese children with/without T2DM may suggest a possible role of these biomarkers in the pathogenesis of childhood obesity and their accompanied complications e.g. inflammations and T2DM. Also, further studies are required to test drugs that antagonize the action miR-29a and miR-122 or upregulate sestrin2 in the management of these cases.

Keywords: Childhood obesity; MiR-29a; Sestrin 2; T2DM; miR-122.

MeSH terms

  • Biomarkers / blood*
  • Blood Glucose / analysis
  • Body Mass Index
  • Case-Control Studies
  • Child
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / diagnosis*
  • Diabetes Mellitus, Type 2 / etiology
  • Diabetes Mellitus, Type 2 / pathology
  • Female
  • Follow-Up Studies
  • Humans
  • Inflammation Mediators / blood*
  • Insulin Resistance
  • Male
  • MicroRNAs / blood*
  • Nuclear Proteins / blood*
  • Pediatric Obesity / complications*
  • Prognosis

Substances

  • Biomarkers
  • Blood Glucose
  • Inflammation Mediators
  • MIRN122 microRNA, human
  • MIRN29a microRNA, human
  • MicroRNAs
  • Nuclear Proteins
  • SESN2 protein, human